CTD O 6.25/40 Tablet is a combination of Chlorthalidone and Olmesartan, which are Thiazide diuretics and Angiotensin-II receptor antagonists, respectively. CTD O 6.25/40 Tablet is used to treat essential hypertension. Essential hypertension (also known as primary hypertension) is a medical disorder in which the force of the blood forced on the artery walls stays extremely high, causing significant damage to the walls of blood arteries feeding numerous vital organs. It develops without any known secondary cause, and if left untreated, it can lead to serious complications such as heart attack, heart or kidney failure, stroke, or even blindness.

Usage instructions-

• The dose and duration of CTD O 6.25/40 Tablet should be taken as directed by your doctor. You can have this drug with meals or without.

How it works-

CTD O 6.25/40 Tablet effectively reduces high blood pressure by blocking the actions of Angiotensin II (a substance that causes blood vessel narrowing and increases in blood pressure) at the angiotensin type-I receptors of vascular smooth muscle and chlorthalidone acts by increasing urinary excretion of sodium and water by inhibiting sodium-chloride reabsorption in the kidneys, resulting in a significant decrease in blood pressure.

Safety information-

Pregnancy

CTD O 6.25/40 Tablet is probably not safe to use in pregnancy. There are limited human studies, but animal studies have shown adverse effects on the developing baby. Consult your doctor.

Breastfeeding

CTD O 6.25/40 Tablet is probably safe to breastfeed. There is limited human data to suggest that the drug poses no risk to the baby.

Alcohol

It may cause excessive drowsiness to take alcohol with CTD O 6.25/40 Tablet.

Driving

CTD O 6.25/40 Tablet may impair your alertness, impair your eyesight, or make you drowsy and dizzy. If you have any of these symptoms, do not drive.

Kidney

CTD O 6.25/40 Tablet should be administered with caution to patients with kidney issues. Dose adjustments may be necessary. Please consult your doctor.

Liver

CTD O 6.25/40 Tablet should be administered with caution to patients with liver issues. Dose adjustments may be necessary. Please consult your doctor.